This follows what appeared to be a generally positive data readout for belrestotug at ESMO 2024 just a few months ago.

Intrepid Labs, a biotechnology company transforming drug formulation development through the use of artificial intelligence (AI) and robotics, emerged from stealth today to accelerate therapeutics ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

The global AI In Life science Analytics Market is projected to be valued at USD 1.9 billion in 2024 and reach USD 3.6 billion ...

Dimerix and its kidney drug is on track but with results of its phase III trial not due for years, a few more twists and turns are likely.

Federal science agencies announce they will de-emphasize animal testing for safety and efficacy of new drugs. San Diego scientists are already finding ways to emphasize new models of human biology.

Donald Trump has announced a new executive order aimed at significantly reducing prescription drug prices in the U.S., ...

Both the NIH and FDA are phasing out animal testing for what their scientists believe are more effective and humane research.

Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect ...

Testing drug compounds on ... explain why there is a 90% failure rate during clinical development. The low rate of success is one of the contributors to the high cost and the slow R&D process ...

President Trump signed an executive order directing pharmaceutical companies to slash U.S. drug prices to match “most favored nation” rates abroad. The order sets 30-day price targets and ...